Sidley Catalyst
The Basics
The Basics
Industry Regulation
Industry Regulation
Liquidity and Exits
Liquidity and Exits
Employee Compensation
Employee Compensation
Data and Privacy
Data and Privacy
Defending Lawsuits
Defending Lawsuits
Everything AI
Everything AI
Life Sciences and Healthcare
Clear Filter
Engineering an Exit: M&A Preparedness for Private Companies
Alison M. Lehner
Amanda Artese
All Articles
Litigation
IP
FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight Paradigm
Raj D. Pai
Jaclyn G. Fonteyne
Andrew James
Julea Lipiz
All Articles
AI
Life Sciences and Healthcare
Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled tools
Dr. Chris Boyle
Zina Chatzidimitriadou
All Articles
Litigation
AI
International
Legal Issues Arising From the Use of Artificial Intelligence in Drug Development
Adriana V. Tibbitts
Alison M. Lehner
Frank Rahmani
Jason Kropp
All Articles
AI
Navigating an Uncertain Market Amidst Cautious Optimism: Steps Biotech Companies Can Take to Hedge Against Financial Fluctuations
Sam Newman
All Articles
M&A
Risk Analysis in the Crosshairs: Four Recent Ransomware Resolutions Preview the HIPAA Security Rule Amendments
Michael C. Hochman
Sasha Hondagneu-Messner
Brad A. Carney
All Articles
Data & Privacy
Litigation
Strategies for Early-Stage Biotech Companies
Adam Welland
All Articles
IP
M&A
Ten To-Do’s For Transitioning From Academia To Entrepreneurship
James Lu
Daniel Wei
All Articles
IP
Financings
UK Looks To Modernize Medicines And Medical Device Regulation In The Era Of AI
Dr. Chris Boyle
Zina Chatzidimitriadou
All Articles
AI
International
When AI Changes the Deal: Rethinking Risk, Milestones, and Timing in Life Sciences M&A
Sally Wagner-Partin
Torrey Cope
Sharon Flanagan
All Articles
AI
M&A
The Basics
Regulatory and Government
Liquidity and Exits
Employee Matters
Defending Lawsuits
IP, Data Privacy, Cybersecurity
